We are live on ! Find out more
MXCT icon

MaxCyte

119 hedge funds and large institutions have $303M invested in MaxCyte in 2024 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 45 increasing their positions, 30 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

211% more call options, than puts

Call options by funds: $84K | Put options by funds: $27K

50% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 30

13% more capital invested

Capital invested by funds: $268M → $303M (+$34.5M)

3.43% more ownership

Funds ownership: 65.4%68.83% (+3.4%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 21

1% less funds holding

Funds holding: 120119 (-1)

Holders
119
Holders Change
-1
Holders Change %
-0.83%
% of All Funds
1.57%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
21
Increased
45
Reduced
30
Closed
21
Calls
$84K
Puts
$27K
Net Calls
+$57K
Net Calls Change
+$62K

MXCT Hedge Fund Activity: Q4 2024 in Review

119 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in MaxCyte (MXCT) for Q4 2024, worth a combined $303M — up 13% from $268M a quarter earlier.

Fund positioning in MXCT was balanced in Q4 2024: 21 funds opened new positions, 21 closed out, 45 added to existing stakes and 30 trimmed.

The largest buyer was Mirabella Financial Services, opening a new position worth an estimated $14M. The largest seller was Millennium Management, cutting an estimated $5.49M.

  • 119 institutional investors held MaxCyte (MXCT) as of Q4 2024, down from 120 in Q3 2024.
  • Funds reported $303M of MaxCyte stock for Q4 2024, up 13% quarter-over-quarter.
  • 21 funds opened new MaxCyte positions in Q4 2024 and 21 closed out, a net change of 0 holders.
  • The largest MaxCyte buyer in Q4 2024 was Mirabella Financial Services, an estimated $14M added.
  • The largest MaxCyte seller in Q4 2024 was Millennium Management, an estimated $5.49M sold.

Based on aggregated 13F filings for Q4 2024.